Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression

被引:127
作者
Kasper, LH
Boussouar, F
Boyd, K
Xu, W
Biesen, M
Rehg, J
Baudino, TA
Cleveland, JL
Brindle, PK
机构
[1] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
关键词
CBP; CH1; HIF; hypoxia; p300;
D O I
10.1038/sj.emboj.7600846
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The C-terminal activation domain (C-TAD) of the hypoxia-inducible transcription factors HIF-1 alpha and HIF-2 alpha binds the CH1 domains of the related transcriptional coactivators CREB-binding protein (CBP) and p300, an oxygen-regulated interaction thought to be highly essential for hypoxia-responsive transcription. The role of the CH1 domain in vivo is unknown, however. We created mutant mice bearing deletions in the CH1 domains (Delta CH1) of CBP and p300 that abrogate their interactions with the C-TAD, revealing that the CH1 domains of CBP and p300 are genetically non-redundant and indispensable for C-TAD transactivation function. Surprisingly, the CH1 domain was only required for an average of similar to 35-50% of global HIF-1-responsive gene expression, whereas another HIF transactivation mechanism that is sensitive to the histone deacetylase inhibitor trichostatin A (TSA(S)) accounts for similar to 70%. Both pathways are required for greater than 90% of the response for some target genes. Our findings suggest that a novel functional interaction between the protein acetylases CBP and p300, and deacetylases, is essential for nearly all HIF-responsive transcription.
引用
收藏
页码:3846 / 3858
页数:13
相关论文
共 43 条
[1]   Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration [J].
Alarcón, JM ;
Malleret, G ;
Touzani, K ;
Vronskaya, S ;
Ishii, S ;
Kandel, ER ;
Barco, A .
NEURON, 2004, 42 (06) :947-959
[2]   TSC2 regulates VEGF through mTOR-dependent and -independent pathways [J].
Brugarolas, JB ;
Vazquez, F ;
Reddy, A ;
Sellers, WR ;
Kaelin, WG .
CANCER CELL, 2003, 4 (02) :147-158
[3]   Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor [J].
Bruick, RK .
GENES & DEVELOPMENT, 2003, 17 (21) :2614-2623
[4]   Loss of HIF-2 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice [J].
Compernolle, V ;
Brusselmans, K ;
Acker, T ;
Hoet, P ;
Tjwa, M ;
Beck, H ;
Plaisance, S ;
Dor, Y ;
Keshet, E ;
Lupu, F ;
Nemery, B ;
Dewerchin, M ;
Van Veldhoven, P ;
Plate, K ;
Moons, L ;
Collen, D ;
Carmeliet, P .
NATURE MEDICINE, 2002, 8 (07) :702-710
[5]   Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response [J].
Dames, SA ;
Martinez-Yamout, M ;
De Guzman, RN ;
Dyson, HJ ;
Wright, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5271-5276
[6]   Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia:: their stabilization and redox signal-induced interaction with CBP/p300 [J].
Ema, M ;
Hirota, K ;
Mimura, J ;
Abe, H ;
Yodoi, J ;
Sogawa, K ;
Poellinger, L ;
Fujii-Kuriyama, Y .
EMBO JOURNAL, 1999, 18 (07) :1905-1914
[7]   Deacetylase activity is required for cAMP activation of a subset of CREB target genes [J].
Fass, DM ;
Butler, JEF ;
Goodman, RH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43014-43019
[8]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[9]   Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α [J].
Freedman, SJ ;
Sun, ZYJ ;
Poy, F ;
Kung, AL ;
Livingston, DM ;
Wagner, G ;
Eck, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5367-5372
[10]   HIF-1 as a target for drug development [J].
Giaccia, A ;
Siim, BG ;
Johnson, RS .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) :803-811